BioVenture

Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.

AusperBio is a clinical-stage biopharmaceutical company focused on developing innovative treatments for hepatitis B and advancing oligonucleotide therapeutics. Utilizing its proprietary Med-Oligo™ ASO platform, AusperBio aims to deliver effective targeted therapies that leverage antisense oligonucleotide technology. The company is dedicated to transforming the treatment landscape for hepatitis B, with an emphasis on finding a cure and providing protection through novel therapeutic approaches. Additionally, AusperBio's research extends to addressing a variety of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases, thereby broadening the potential impact of its therapeutic innovations.

Shenzhen CardioACC Ltd specializes in advanced cardiovascular interventional, natural cavity imaging and advanced diagnostic procedures.

Huili Pharmaceutical is a drug delivery platform that specializes in the development of nanoparticles and microsphere preparation equipment.

Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterol monitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.

Essentia Biosciences is a biotechnology company that specializes in the development of cells, gene technology drugs, and medical devices.

Chime Biologics Limited is a Contract Development and Manufacturing Organization (CDMO) based in Wuhan, China, specializing in biopharmaceutical development and manufacturing services. Established in 2013, the company offers a wide range of services, including drug substance and drug product manufacturing, cell line development, and protein science characterization. It also supports clients with technical transfer, regulatory guidance, and project management to ensure a comprehensive solution throughout the biopharmaceutical development lifecycle. Chime Biologics focuses on delivering customer-centric, cost-effective, high-quality services that cater to the evolving needs of the biopharmaceutical industry, facilitating early-stage development through late-stage clinical research and commercial production.

Power Site is a modern technology enterprise that supplies X-ray imaging core components. It mainly provides high-voltage generators (HVG), combined X-ray sources, power distribution units (PDU), and other core components overall solutions for X-ray imaging systems. The products are mainly used in high-end X-ray imaging systems such as CT, DR, mammography, C-arm, CBCT, security inspection, industrial inspection, etc. The company has an advanced and efficient manufacturing platform with an annual production capacity of 50,000 units.

Eco Polymer specializes in designing and manufacturing plastic tubes and parts. They provide products for polyethylene, polypropylene, polyamine, elastomers, fluoropolymers, and other various polymers. They serve the medical instrument, auto, electronics, fiber optics, semiconductor, chemical engineering, environment, and analytics industries.

Hanchao Pharmaceutical is a biopharmaceutical company that specializes in the development and production of medical equipment and solutions for the biomedical industry. The company's core focus is on providing single-use bioprocessing solutions, with a particular emphasis on biomedical production technology. Hanchao independently designs, manufactures, and sells a range of equipment and consumables, catering to the industrialization stage of various biomedical fields, including antibodies, vaccines, antibody-drug conjugates (ADCs), and cell and gene therapies (CGTs).

Pulnovo Medical, established in 2013 in Wuxi, Anhui, is focused on the development, production, and service provision of innovative medical technologies. The company specializes in creating advanced equipment for treating pulmonary hypertension, particularly through the use of pulse radiofrequency ablation technology. Its core products include pioneering high-frequency ablation equipment and intravascular catheters, which are protected by global invention patents. Pulnovo Medical aims to enhance the quality of life for patients suffering from pulmonary hypertension and heart failure by offering cutting-edge treatment solutions.

Zhongguancun Shuimu Medical Technology is the operator of a third-party, competent medical device compliance organization. Their business helps companies cut costs and time to market by offering medical device compliance services. It is dedicated to accelerating the registration and listing procedures for new medical device items as well as addressing the issue of how to industrialize creative medical device firms.

Joymed Technology specializes in the research and development, registration, and manufacturing of medical devices, providing comprehensive solutions tailored for medical equipment businesses. The company focuses on delivering innovative and reliable technology while ensuring high-quality standards in its products. By offering services such as device design, risk management, marketing, and product verification and validation, Joymed Technology enables its clients to develop and launch safe and affordable medical products efficiently. The company aims to become a trusted partner for both domestic and international medical device firms, particularly assisting small and medium-sized enterprises in navigating the complexities of the medical product market. Through flexible collaboration and optimized design processes, Joymed Technology seeks to accelerate mutual growth with its customers.

AccuPulse specializes in the development of advanced pulsed electric field ablation (PFA) systems designed for the treatment of atrial fibrillation (A-fib). The company focuses on creating innovative PFA generators and specialized catheters that serve as a comprehensive solution for the pulse ablation of A-fib and tumors. By integrating technologies that enhance catheter localization and signal acquisition, AccuPulse provides a more efficient and intelligent alternative to traditional interventional therapies, including radio frequency and cryotherapy. This approach aims to improve outcomes for both healthcare providers and patients by offering a more effective treatment option.

KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company focuses on creating a comprehensive range of biological heart valves and annuloplasty rings that are designed to be minimally invasive. Utilizing cutting-edge technologies, including anti-calcification and leaflet thinning methods, KingstronBio aims to provide innovative solutions that enhance patient outcomes and improve the overall effectiveness of cardiac procedures.

Tripod Preclinical Research is a Contract Research Organization that specializes in preclinical research services tailored for the biopharmaceutical industry. The company offers a comprehensive range of services, including nonhuman primate disease models, pharmacological efficacy assessments, early drug evaluations, and GLP toxicology. Tripod is committed to supporting global pharmaceutical companies, research and development enterprises, and medical device manufacturers in the evaluation of new chemical entities, food additives, biologics, pesticides, veterinary drugs, and cosmetics. Additionally, the organization provides technology support in areas such as translational medicine, clinical trials, biological analysis, and the management of biological sample banks, ensuring that its clients have the necessary resources to advance their research and development efforts effectively.

Guangzhou Creative Biosciences, established in Guangzhou, China, specializes in the research, development, production, and sales of diagnostic kits for colorectal cancer screening. Their primary product is a non-invasive fecal DNA screening kit, which enables early detection of colorectal cancer by interpreting genetic abnormalities in feces. Additionally, the company offers diagnostic kits and equipment for lung cancer.

Vision X is a solutions provider for medical equipment in the field of ophthalmology and optometry.

IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

Brattea is a medical device research and development company specializing in renal denervation products aimed at addressing various health conditions, including hypertension, cancer pain, and diabetes. The company develops interventional devices that include renal artery ablation catheters, radiofrequency ablation equipment, and medical mapping systems. These products are designed to treat a range of medical issues, such as refractory hypertension, obstructive sleep apnea, kidney disease, and heart failure. Through its innovative approach, Brattea aims to provide reliable solutions that improve patient outcomes and enhance the quality of care in the medical field.

Synaptic Medical Inc. is a medical device company dedicated to developing and commercializing innovative products aimed at treating cardiac arrhythmias and other cardiovascular diseases. Established in 2005 and headquartered in St. Paul, Minnesota, the company also maintains an office in Beijing, China. Synaptic Medical specializes in cardiac electrophysiology, offering a range of products including bipolar pacing systems, fixed curve and deflectable diagnostic catheters, pulmonary vein mapping catheters, and ablation devices. The company's focus is on creating unique, cost-effective, and clinically advanced technologies that enhance treatment options for physicians and their patients.

Tavotek Biotherapeutics is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients with significant unmet medical needs in cancers, autoimmune conditions, and infectious diseases. The company utilizes three platform technologies—TavoSelect, a phage display library; TavoPrecise, an engineering platform for tissue-specific biologics; and TavoMIP, a multicyclic peptide platform—to advance a diverse pipeline across multiple development stages. Its leadership includes veteran pharmaceutical executives and advisors with experience in bringing biologics to market.

Huikai Medical is a specialized manufacturer and developer of minimally invasive urological medical devices. Its product portfolio focuses on addressing key urinary system conditions such as prostatic hyperplasia, urinary stones, incontinence, and urological tumors. The company's innovative devices are designed to enhance patient comfort and efficiency in medical settings, utilizing proprietary technology and materials for superior clinical outcomes.

Yingsheng Biotechnology Co., Ltd., established in 2009, specializes in the development of in vitro diagnostic reagents and medical equipment focused on maternal and child health, neonatal genetic diseases, metabolic disorders, and birth defects. The company offers a diverse product line that includes 45 innovative screening reagents for genetic metabolic diseases, deaf genetic testing kits, vitamins determination reagents, and an HLA-B27 detection kit. Yingsheng also provides advanced diagnostic technologies such as a mass spectrometer automatic intelligent processing platform and ultra-high performance liquid chromatography tandem mass spectrometry detection systems. Through its innovative products, Yingsheng aims to facilitate early detection of genetic conditions, promoting timely intervention and better health outcomes for patients.

GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. The company utilizes high-throughput sequencing technology combined with intelligent algorithm analysis to address challenges associated with traditional diagnostic methods, such as low detection rates, lengthy processes, and accuracy issues. By improving the timeliness and precision of pathogen diagnosis, GensKey enables patients suffering from severe infections to receive prompt and reliable diagnoses, thereby enhancing the potential for effective treatment and recovery.

Founded in Hangzhou, China in 2012 by experienced professionals from leading global device makers, Zylox specializes in developing and distributing high-quality interventional and implantable peripheral vascular devices. Its product portfolio includes PTA balloons, drug-coated balloons, SFA stents, and other vascular accessories, aiming to improve patient outcomes worldwide.

Beijing Delta Medical Co., Ltd. specializes in the design and manufacture of orthopedic surgical instruments and rehabilitation products. The company offers a range of products, including shoulder arthroscopic instruments, various types of suture anchors, instruments for anterior and posterior cruciate ligament reconstruction, interference screws, and shaver systems. In addition to its surgical instruments, Delta Medical provides sports rehabilitation services. The company is headquartered in Beijing, China, and focuses on delivering innovative solutions in sports medicine.

IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

Shanghai Bioheart Biotechnology Co., Ltd., established in 2014 and located in Shanghai, China, specializes in the development of drug-eluting stents. The company is focused on creating innovative, high-value minimally invasive therapeutic products. Bioheart aims to enhance medical technology and provide superior healthcare solutions for medical professionals and patients alike, positioning itself as a significant player in the medical and healthcare industry.

EOC Pharma Group is a biopharmaceutical company based in Shanghai, China, founded in 2015. It specializes in the development, manufacturing, and commercialization of innovative oncology products. EOC employs a licensing model to enhance its product pipeline by incorporating molecules from global biopharmaceutical partners into its robust local infrastructure, which includes manufacturing, clinical development, regulatory filing, and commercialization. The company has a diverse pipeline featuring seven novel products, several of which are positioned as potentially first- and best-in-class. EOC has achieved regulatory milestones with four Class I innovative drug approvals and has initiated clinical studies for its leading products. The company operates an 8,000 square meter cGMP manufacturing facility in Taizhou and maintains offices in key locations, including Shanghai, Beijing, Hong Kong, and Los Angeles. With a team of experienced professionals, EOC aims to establish itself as a leader in oncology innovation in China through strategic partnerships and a comprehensive integrated platform.

Ruixun Biotech is a healthcare company that provides biotechnology. Ruixun Biotech combines microfluidics, optics, precision instruments, electronic engineering, and biochemical technologies to create upstream equipment and consumables for molecular diagnosis and genetic testing. They released a number of products, including the digital PCR apparatus DropX-2000 and more than 50 different RUO detection kits.

Founded in 2015, DiaMonTech specializes in developing non-invasive medical diagnostic devices. Its proprietary photo-thermal detection technology enables accurate glucose level measurements without finger pricking or blood samples.

Antai Kangcheng is a research and development company specializing in tumor electric field treatment technology, particularly aimed at addressing glioblastoma multiforme. The company is dedicated to creating innovative treatment methods and equipment for tumor management and central nervous system injury rehabilitation. Antai Kangcheng has developed a precise treatment planning system that integrates biophysical models with multimodal imaging systems, allowing for personalized treatment solutions tailored to the needs of Chinese patients. Furthermore, the company has achieved the visualization of intracranial electric field strength and can effectively manage electro-nodes to track tumors, enabling patients to receive effective treatment at a lower cost.

Just Medical is a developer and manufacturer of artificial orthopedic implant devices and systems, specializing in products such as artificial hip and knee joints, internal fixation products, and orthopedic surgical instruments. The company is dedicated to enhancing surgical efficiency and improving the quality of orthopedic treatment through advanced technology research and development. Just Medical focuses on creating safe and effective medical products and services, continually refining its product system to address the needs of healthcare providers and alleviate patient pain. Its commitment to high-speed development and excellence positions it as a key player in the orthopedic medical device industry.

Joinspine is one of the few Chinese companies that have some core patients in the field of spinal surgery and spine endoscopy industry. The current team is using the latest new technologies to improve its auxiliary robot and AI. Based on advanced foreign technologies and their own Development, Jlecheng Medical believes they can help this industry to improve in China.

Yingsheng Biotechnology Co., Ltd., established in 2009, specializes in the development of in vitro diagnostic reagents and medical equipment focused on maternal and child health, neonatal genetic diseases, metabolic disorders, and birth defects. The company offers a diverse product line that includes 45 innovative screening reagents for genetic metabolic diseases, deaf genetic testing kits, vitamins determination reagents, and an HLA-B27 detection kit. Yingsheng also provides advanced diagnostic technologies such as a mass spectrometer automatic intelligent processing platform and ultra-high performance liquid chromatography tandem mass spectrometry detection systems. Through its innovative products, Yingsheng aims to facilitate early detection of genetic conditions, promoting timely intervention and better health outcomes for patients.

CART Medical Technologies is a high-tech company focused on advancing immune cell therapy through innovative technologies. The company specializes in developing CAR-T cells, which can target both protein antigens and glycolipid non-protein antigens, thereby expanding the range of tumor antigen targets. This approach enhances T-cell generation and activation, leading to more effective treatments for various diseases. CART Medical operates out of a 2,200 square meter facility that includes GMP laboratory and research and development laboratories.

Isia Biotech is a developer and producer of in vitro diagnostic (IVD) medical technology that focuses on detecting and diagnosing diseases through immune reactions. The company utilizes its proprietary quantum dot technology to enhance the accuracy of tests for various medical conditions, including cardiovascular disease, inflammation, bone metabolism, gastric function, renal function, cancer, and other autoimmune diseases. By advancing diagnostic capabilities, Isia Biotech aims to support healthcare providers in improving disease detection, diagnosis, and treatment. Their commitment to research and development, alongside the production and sales of diagnostic instruments, positions them as a significant player in the medical technology sector.

DeepCyto is a medtech company based in Suzhou, Jiangsu, China, established in 2018. The company specializes in the development of digital hematology pathology and diagnostic equipment, incorporating artificial intelligence and deep learning technologies to enhance medical diagnosis and data analysis. By leveraging machine vision and big data mining, DeepCyto offers intelligent diagnostic models that address various blood diseases, aiming to improve the accuracy and efficiency of medical assessments.

Novaprint Therapeutics develops and supplies regenerative medical implant devices. The company utilizes 3D printing technology to design and develop regenerative medical implant devices, enabling patients to receive more customized and effective medical treatment.

AGS MedTech is a company based in Hangzhou that specializes in the research, development, production, and sales of endoscopic devices designed for minimally invasive diagnosis and treatment. The firm focuses on creating innovative surgical solutions that enhance patient care by minimizing pain and reducing medical costs. By prioritizing safety and efficiency, AGS MedTech aims to provide both patients and clinicians with advanced tools that facilitate effective medical procedures. Through its commitment to quality and innovation, the company seeks to improve the overall healthcare experience.

Innovita Biological Technology Co., Ltd., established in 2006 in Beijing, is a Chinese biotechnology company specializing in the research, development, manufacturing, marketing, and after-sales service of in-vitro diagnostic tests. In 2011, the company expanded by opening a new facility in Tangshan, Hebei province, which includes five production lines for colloidal gold, real-time PCR, chemiluminescence, ELISA, and biochips. This facility spans 250 acres and features a 4,000-square-meter purification plant, with a designed annual output of up to 20 million tests. Innovita holds ten invention patents and has received certifications such as CE, ISO 13485, and GMP. Its extensive product line includes tests for fertility, infectious diseases, sexually transmitted diseases, respiratory diseases, drug abuse, tumor markers, and cardiac markers.

Beijing Delta Medical Co., Ltd. specializes in the design and manufacture of orthopedic surgical instruments and rehabilitation products. The company offers a range of products, including shoulder arthroscopic instruments, various types of suture anchors, instruments for anterior and posterior cruciate ligament reconstruction, interference screws, and shaver systems. In addition to its surgical instruments, Delta Medical provides sports rehabilitation services. The company is headquartered in Beijing, China, and focuses on delivering innovative solutions in sports medicine.

Ningbo Senscure Biotechnology Co., Ltd specializes in the innovation and enhancement of minimally invasive surgery technologies, focusing primarily on single incision laparoscopic surgery (SILS) and natural orifice transluminal endoscopic surgery (NOTES). The company is dedicated to tumor treatment and offers a range of surgical devices, including a laparoscopic single port multi-channel access platform, a pulmonary nodule localization needle, a tumor cryoablation system, and an anti-gastroesophageal reflux system. Senscure provides comprehensive medical equipment solutions designed to facilitate minimally invasive surgeries.

Cryofocus Biotech is a Shanghai-based cryoablation device manufacturer, focusing on the application of cryogenic technology in the field of cardiovascular interventional therapy.

Claricare Medical is an innovative developer of oncology vascular interventional therapeutic services.

LenoMed Medical is a manufacturer of medical devices focused on improving diabetes management. With over 15 years of research and development experience in infusion technology, the company specializes in creating innovative products such as the InnoTech insulin pump, drug infusion pumps, and related disposables. LenoMed is dedicated to enhancing diabetes care through the integration of continuous glucose monitoring technology with their insulin pumps, aiming to provide patients with better treatment options and monitoring capabilities. Their commitment to advancing diabetes management is reflected in their comprehensive diabetes care management system.

KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company focuses on creating a comprehensive range of biological heart valves and annuloplasty rings that are designed to be minimally invasive. Utilizing cutting-edge technologies, including anti-calcification and leaflet thinning methods, KingstronBio aims to provide innovative solutions that enhance patient outcomes and improve the overall effectiveness of cardiac procedures.

Aixing Biotechnology manufacture biopharmaceutical and IVD equipment for healthcare services.

Dymind specializes in the development, manufacture, sale, and service of medical devices.

Admera Health, LLC is a molecular diagnostics company based in South Plainfield, New Jersey, specializing in personalized medicine and non-invasive cancer testing. Founded in 2012, the company operates a laboratory that develops, validates, and delivers proprietary laboratory-developed tests. Admera Health offers a range of services, including PGxOne, a pharmacogenomics test that assesses patient responses to drug therapy based on genetic makeup, and DNA sequencing for analyzing mutations in EGFR and KRAS. Additionally, it provides tests to evaluate risks for inherited health conditions such as high cholesterol and diabetes. The company's product pipeline includes the OncoGxOne cancer panel, which identifies genomic variations related to cancer, and FloraCheck, which analyzes microbiome composition for health management. Utilizing advanced genomic technologies and bioinformatics, Admera Health aims to enhance disease screening, diagnosis, and treatment, ultimately improving health outcomes for patients and supporting healthcare providers and researchers.

MID Labs was founded by Dr. Carl Wang in 1981 and has been associated with vitreoretinal surgery from its infancy. Not only has MID Labs invented the tools for modern vitrectomy, but as a company, it has been instrumental in revolutionizing the ophthalmic field through its products. MID Labs continues to innovate with the MID Labs branded product line which is supplied to more than 30 countries around the world. These products set the standard for precision, performance, and quality.

AusperBio is a clinical-stage biopharmaceutical company focused on developing innovative treatments for hepatitis B and advancing oligonucleotide therapeutics. Utilizing its proprietary Med-Oligo™ ASO platform, AusperBio aims to deliver effective targeted therapies that leverage antisense oligonucleotide technology. The company is dedicated to transforming the treatment landscape for hepatitis B, with an emphasis on finding a cure and providing protection through novel therapeutic approaches. Additionally, AusperBio's research extends to addressing a variety of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases, thereby broadening the potential impact of its therapeutic innovations.